ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

ImageneBio total assets

Total assets on the balance sheet at the end of each period.

ImageneBio's total assets was $142.54M at Sep 30, 2026. For fiscal 2025 it was $152.98M, up 860.8% from the year before. The highest annual figure on record is $247.88M in fiscal 2021.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$152.98M	+860.8%
FY2024	Dec 31, 2024	$15.92M	-91.7%
FY2023	Dec 31, 2023	$192.09M	+11.5%
FY2022	Dec 31, 2022	$172.26M	-30.5%
FY2021	Dec 31, 2021	$247.88M	+47.2%
FY2020	Dec 31, 2020	$168.40M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$142.54M	-11.4%
Q2 FY2026	Jun 30, 2026	$152.05M	+20.5%
Q1 FY2026	Mar 31, 2026	$136.68M	+4.5%
Q4 FY2025	Dec 31, 2025	$152.98M	+860.8%
Q3 FY2025	Sep 30, 2025	$160.88M	+8.0%
Q2 FY2025	Jun 30, 2025	$126.17M	-19.9%
Q1 FY2025	Mar 31, 2025	$130.84M	-24.3%
Q4 FY2024	Dec 31, 2024	$15.92M	-91.7%
Q3 FY2024	Sep 30, 2024	$148.99M	-30.8%
Q2 FY2024	Jun 30, 2024	$157.49M	-8.3%
Q1 FY2024	Mar 31, 2024	$172.78M	+13.4%
Q4 FY2023	Dec 31, 2023	$192.09M	+11.5%
Q3 FY2023	Sep 30, 2023	$215.34M	+13.1%
Q2 FY2023	Jun 30, 2023	$171.76M	-18.7%
Q1 FY2023	Mar 31, 2023	$152.40M	-33.1%
Q4 FY2022	Dec 31, 2022	$172.26M	-30.5%
Q3 FY2022	Sep 30, 2022	$190.47M	-27.2%
Q2 FY2022	Jun 30, 2022	$211.18M	-24.3%
Q1 FY2022	Mar 31, 2022	$227.75M	-22.4%
Q4 FY2021	Dec 31, 2021	$247.88M	+47.2%
Q3 FY2021	Sep 30, 2021	$261.71M	–
Q2 FY2021	Jun 30, 2021	$278.83M	–
Q1 FY2021	Mar 31, 2021	$293.66M	–
Q4 FY2020	Dec 31, 2020	$168.40M	–